Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New York Life Investment Management (NYLIM) is a premier global asset management firm and a wholly-owned subsidiary of New York Life Insurance Company. The firm offers a diverse range of investment solutions, including mutual funds, exchange-traded funds (ETFs), and institutional asset management services. Operating through a multi-boutique model, NYLIM manages assets across various classes such as fixed income, equities, and alternative investments. While the firm may invest in healthcare and life sciences companies as part of its portfolio, it does not engage in drug discovery or clinical development. NYLIM serves a broad client base including retail investors, pension funds, and other institutional entities worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New York Life Investment Management.